AI’s role in CRISPR is widening after a new RNA-recognizing molecular kill switch
nathanbenaich · x · 2026-07-29
Nathan Benaich points to a podcast with Profluent Bio about where AI fits into CRISPR and gene editing.
The reply highlights a recent result described as a molecular kill switch that recognizes a specific RNA, with one researcher calling it "basically a programmable chemotherapy." The implication is that AI-enabled biological design is expanding the therapeutic space for CRISPR companies.
More from Research
- Cradle Codec: GPU-Native KV Cache Compression Explained — knowrohit07 · 2026-07-29
- TransluceAI proposes oversight foundation models to catch reward hacking at scale — JacobSteinhardt · 2026-07-29
- Why tokenizers still resist end-to-end optimization despite years of pretraining — seanmcdonaldxyz · 2026-07-29
- Student builds a local coding agent on molab and beats two 7B coder baselines — S_Conradi · 2026-07-29
- TILT improves compositional text-to-image generation with a model-intrinsic reward — Debottam Dutta · 2026-07-29
- A KLS conjecture breakthrough links convex geometry, Monge–Ampère PDEs and ChatGPT — lihua_lei_stat · 2026-07-29